All In Biotech

Drug Trial Radar · NCT04784533

A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

A Study to Evaluate Maintenance of Hair Regrowth Following Dose Reduction of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Last checked: Nov 19, 2026Latest source record: Oct 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 317 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

317

Actual

Start

Feb 26, 2021

Primary completion

May 16, 2023

Study completion May 16, 2023

Sponsor

Lead sponsor
Concert PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 5, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the regrowth of hair with CTP-543 and subsequent durability of that regrowth following dose reduction in adult patients with moderate to severe alopecia areata.

Conditions

  • Alopecia Areata

Interventions

  • CTP-543Drug

    Oral dosing

  • PlaceboDrug

    Oral dosing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A, Period 2: Percentage of Participants Achieving Loss of Regrowth Maintenance (LOM) Criteria Defined by Severity of Alopecia Tool (SALT) Score > 20 Following Dose ReductionTime frame: From Week 24 to Week 48
  2. Part A, Period 2: Percentage of Participants Achieving LOM Criteria Defined by SALT Score > 20 Following Drug DiscontinuationTime frame: From Week 24 to Week 48
  3. Part B: Percentage of Participants by Dose Group Who Achieved Restoration of Regrowth (ROR) at Week 24Time frame: Week 24 of re-treatment

Locations

39 sites in 1 country. Site status is shown where the registry gives one.

  • Total Skin and Beauty Dermatology Center, PC

    Birmingham, Alabama

  • Center for Dermatology and Plastic Surgery/CCT Research

    Scottsdale, Arizona

  • Kern Research, Inc.

    Bakersfield, California

  • Hope Clinical Research

    Canoga Park, California

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • University of California, Irvine

    Irvine, California

  • Quest Dermatology Research

    Northridge, California

  • Kaiser Permanente

    Oakland, California

  • Palmtree Clinical Research, Inc.

    Palm Springs, California

  • Kaiser Permanente

    San Francisco, California

  • Colorado Center for Dermatology and Skin Surgery

    Centennial, Colorado

  • Colorado Medical Research Center, Inc.

    Denver, Colorado

  • Yale University Church Street Research Unit

    New Haven, Connecticut

  • Skin Care Research, LLC

    Boca Raton, Florida

  • Skin Care Research, LLC

    Hollywood, Florida

  • DeNova Research

    Chicago, Illinois

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • DS Research

    Louisville, Kentucky

  • Michigan Center for Research Company, LLC

    Clarkston, Michigan

  • University of Minnesota Department of Dermatology

    Minneapolis, Minnesota

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • Skin Specialists, PC

    Omaha, Nebraska

  • Skin Laser and Surgery Specialists of New Jersey

    Hackensack, New Jersey

  • Darst Dermatology

    Charlotte, North Carolina

  • Dermatology Specialists of Charlotte

    Charlotte, North Carolina

  • North Carolina Dermatology Associates, PLLC

    Raleigh, North Carolina

  • Bexley Dermatology Research

    Bexley, Ohio

  • Remington Davis

    Columbus, Ohio

  • Vital Prospects Clinical Research Institute, PC

    Tulsa, Oklahoma

  • Northwest Dermatology

    Portland, Oregon

  • Dermatology Associates of Plymouth Meeting

    Plymouth Meeting, Pennsylvania

  • PEAK Research, LLC

    Upper Saint Clair, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Clinical Research Center of the Carolinas

    Charleston, South Carolina

  • Dermatology Treatment and Research Center, PA

    Dallas, Texas

  • Austin Institute for Clinical Research

    Houston, Texas

  • Austin Institute for Clinical Research, Inc.

    Pflugerville, Texas

  • Springville Dermatology/CCT Research

    Springville, Utah

  • West End Dermatology Associates

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.